Streetbeat News

Products Services

SGMO

Sangamo Therapeutics has received Fast Track Designation from the U.S. FDA for its gene therapy product candidate, isaralgagene civaparvovec (ST-920), for the treatment of Fabry disease. The designation aims to expedite the development and review of new therapeutics for serious conditions with unmet medical needs.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:09 pm

AEMD

INDA

Aethlon Medical (NASDAQ:AEMD) has received Ethics Review Board approval to add a second site, Maulana Azad Medical College, to its ongoing clinical trial of Hemopurifier for treating severe COVID-19 in India. The trial aims to enroll up to 15 patients across three centers.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:08 pm

YGF

YanGuFang International Group (NASDAQ:YGF) has partnered with China Jilin Baicheng Academy of Agricultural Sciences to establish the Collaborative Innovation Center for Whole Grain Seed Industry Technology. The partnership aims to enhance breeding techniques and expedite the introduction of new whole grain products to the market.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:05 pm

RAIN

Rain Oncology's Phase 3 MANTRA trial of Milademetan in dedifferentiated liposarcoma did not meet its primary endpoint of progression-free survival, compared to the standard of care, Trabectedin.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:04 pm

RYTM

Rhythm Pharmaceuticals and Genpharm have announced a collaboration to provide IMCIVREE to patients in Gulf Cooperation Council countries. This partnership aims to expand access to the obesity treatment drug.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:03 pm

FRLN

Freeline has been granted ILAP designation by the UK's MHRA for FLT201, an investigational gene therapy for the treatment of Gaucher disease.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:01 pm

FCEL

GTLS

FuelCell Energy (FCEL) and Chart Industries (GTLS) signed a Memorandum of Understanding (MOU) to collaborate on decarbonization and hydrogen technologies. The partnership aims to combine their strengths in CO2 capture, hydrogen generation, and storage.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:01 pm

AAPL

META

Meta Platforms Inc. (NASDAQ:META) is reportedly in discussions with Magic Leap for a multi-year intellectual property licensing and manufacturing agreement. The collaboration aims to maintain Meta's edge against Apple Inc. (NASDAQ:AAPL) in the augmented reality space.

Portfolio Pulse from Ananya Gairola

May 22, 2023 | 11:57 am

AAPL

GOOG

GOOGL

META

MSFT

Apple is expected to unveil its $3,000 mixed-reality headset at the Worldwide Developers Conference on June 5. Gene Munster of Deepwater Asset Management believes most investors expect the product to be closer to a disappointment than a success. If the headset is a hit, it could account for 10% of Apple's revenue in 2030.

Portfolio Pulse from Shanthi Rexaline

May 22, 2023 | 11:52 am

TSM

TSMC has secured significant AI chip orders and is experiencing an increase in demand for generative AI, according to DigiTimes sources.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 11:42 am